Last reviewed · How we verify
NCT06072235
Facemasks and Chronic Pain Patients With Hearing Loss
trial testing Verbal communication in Hearing Loss in 500 participants. Completed in 11 December 2024.
11 December 2024
Quick facts
| Lead sponsor | Salem Anaesthesia Pain Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 8 January 2018 |
| Primary completion | 11 December 2024 |
| Estimated completion | 11 December 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Verbal communication
Conditions studied
- Hearing Loss — all drugs for Hearing Loss →
- Chronic Pain — all drugs for Chronic Pain →
Sponsor
Salem Anaesthesia Pain Clinic
Who can join
Adults 20 to 99, any sex, with Hearing Loss or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Facemasks may impede communication. Impaired communication may worsen healthcare outcomes. This study explores the problem of hearing impairment in chronic pain patients, and the impact of facemasks on healthcare outcomes in chronic pain patients. Data collection includes patient's age, anxiety score, depression score, numeric pain score, and effects of facemasks on treatment outcomes. Pain is measured using numeric pain rating scale. Depression is measured using the Patient Health Questionnaire (PHQ-9) scale. Anxiety is measured using the General Anxiety Disorder (GAD-7) scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06072235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other Salem Anaesthesia Pain Clinic trials
Trials by the same sponsor.
- NCT05898529 — COVID Infection in Pediatric Surgical Patient · recruiting
- NCT05618002 — Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients · recruiting
- NCT05277038 — Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients · completed
- NCT06802562 — Medical Assistance in Dying Requests in Pain Clinic · completed
- NCT05950243 — COVID-19 Disease & Vaccine Survey in Africa · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06072235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salem Anaesthesia Pain Clinic
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06072235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing